Regents of the University of California Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$4.13M |
| 2 |
Estee Lauder
EL
|
+$3.06M |
| 3 |
Coca-Cola
KO
|
+$795K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$244K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$1.94M |
| 2 |
HAPN
Happen Inc
HAPN
|
+$1.78M |
| 3 |
Shutterstock
SSTK
|
+$744K |
| 4 |
CytomX Therapeutics
CTMX
|
+$514K |
| 5 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$421K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.78% |
| 2 | Consumer Staples | 17.61% |
| 3 | Healthcare | 12.63% |
| 4 | Energy | 11.91% |
| 5 | Financials | 11.12% |
Similar funds
Regents of the University of California's Q2 2017 Portfolio in Review
As of Q2 2017, Regents of the University of California held 26 positions worth $22.8M, up 12% from $20.4M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Regents of the University of California deployed $2.03M of net new capital in Q2 2017, opening 4 new positions. Its largest new stake was Block Inc: 200,000 shares worth $4.69M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 2.6% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was CytomX Therapeutics, an estimated $514K trimmed.
- Regents of the University of California's largest Q2 2017 buy was Block Inc: 200,000 shares worth $4.69M.
- Regents of the University of California's biggest Q2 2017 reduction was CytomX Therapeutics, cutting an estimated $514K.
- Regents of the University of California fully exited Trip.com Group in Q2 2017, selling an estimated $1.94M.
- Regents of the University of California's ten largest holdings make up 80% of its $22.8M portfolio in Q2 2017.
- Regents of the University of California opened 4 new positions and closed 7 in Q2 2017.
- Regents of the University of California's portfolio value rose 12% quarter-over-quarter to $22.8M.
Based on Regents of the University of California's 13F filing for Q2 2017, filed 21 Aug 2017.